<?xml version="1.0" encoding="UTF-8"?>
<ref id="B55">
 <label>55</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kochenderfer</surname>
    <given-names>JN</given-names>
   </name>
   <name>
    <surname>Dudley</surname>
    <given-names>ME</given-names>
   </name>
   <name>
    <surname>Kassim</surname>
    <given-names>SH</given-names>
   </name>
   <name>
    <surname>Somerville</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Carpenter</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Stetler-Stevenson</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor</article-title>. 
  <source>J Clin Oncol</source> (
  <year>2015</year>) 
  <volume>33</volume>(
  <issue>6</issue>):
  <page-range>540–9</page-range>.  
  <pub-id pub-id-type="doi">10.1200/JCO.2014.56.2025</pub-id>
 </mixed-citation>
</ref>
